跳至主要内容
临床试验/IRCT20190604043813N2
IRCT20190604043813N2招募中3 期

Evaluating the Effect of Ursodeoxycholic Acid on total bilirubin of neonate with neonatal indirect hyperbilirubinemia who have Glucose-6-phosphate dehydrogenase deficiency compare to control group

Shiraz University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
1 day 至 10 days(—)
性别
All

入选标准

  • Exclusive breastfeeding,
  • Total bilirubin levels above 14 mg / dL and below 20 mg / dL,
  • Direct bilirubin levels below 2 mg / dL.
  • Age above 1 day
  • Glucose 6 phosphate dehydrogenase deficiency
  • Parent consent

排除标准

  • Infection and septicemia
  • Uunderlying disease such as heart and liver disease
  • The diabetic mother
  • Rh incompatibility

研究者

相似试验